PWA
ABCL icon

Physician Wealth Advisors’s AbCellera Biologics ABCL Stock Holding History

Physician Wealth Advisors’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-168
Closed -$846 – 2028
2025
Q3 		$846 Buy
+168
New +$740 ﹤0.01% 1669
2025
Q1 		– Sell
-593
Closed -$1.74K – 1438
2024
Q4 		$1.74K Buy
+593
New +$1.65K ﹤0.01% 863

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Physician Wealth Advisors's ABCL Position: Q4 2025 in Review

Physician Wealth Advisors sold out of AbCellera Biologics (ABCL) in Q4 2025, closing a stake of 168 shares — an estimated $846 sold.

Physician Wealth Advisors first reported a position in ABCL in Q4 2024 and held it in 2 quarters. The position peaked at $1.74K in Q4 2024. 144 funds tracked by Wall St. Rank hold ABCL as of Q4 2025.

  • Physician Wealth Advisors reported no remaining AbCellera Biologics position as of Q4 2025 after selling out during the quarter.
  • Physician Wealth Advisors sold 168 AbCellera Biologics shares in Q4 2025, an estimated $846.
  • Physician Wealth Advisors first reported a position in AbCellera Biologics in Q4 2024 and held it in 2 quarters.
  • Physician Wealth Advisors's AbCellera Biologics position peaked at $1.74K in Q4 2024.
  • 144 funds tracked by Wall St. Rank held AbCellera Biologics as of Q4 2025.

Based on Physician Wealth Advisors's 13F filing for Q4 2025, filed 29 Jan 2026.